Cognition Therapeutics Inc [NASDAQ: CGTX] closed the trading session at $0.41.
The stocks have a year to date performance of -78.00 percent and weekly performance of -12.04 percent. The stock has been moved at -81.50 percent over the last six months. The stock has performed -27.95 percent around the most recent 30 days and changed -41.69 percent over the most recent 3-months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
If compared to the average trading volume of 491.06K shares, CGTX reached to a volume of 46948235 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Cognition Therapeutics Inc [CGTX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CGTX shares is $7.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CGTX stock is a recommendation set at 1.33. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Cantor Fitzgerald have made an estimate for Cognition Therapeutics Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on July 30, 2024. While these analysts kept the previous recommendation, Oppenheimer raised their target price to Outperform. The new note on the price target was released on November 03, 2021, representing the official price target for Cognition Therapeutics Inc stock. Previously, the target price had yet another raise to $27, while B. Riley Securities analysts kept a Buy rating on CGTX stock.
The Average True Range (ATR) for Cognition Therapeutics Inc is set at 0.05 The Price to Book ratio for the last quarter was 1.15, with the Price to Cash per share for the same quarter was set at 0.54.
CGTX stock trade performance evaluation
Cognition Therapeutics Inc [CGTX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -12.04. With this latest performance, CGTX shares dropped by -27.95% in over the last four-week period, additionally sinking by -81.50% over the last 6 months – not to mention a drop of -59.70% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CGTX stock in for the last two-week period is set at 37.12, with the RSI for the last a single of trading hit 31.37, and the three-weeks RSI is set at 39.18 for Cognition Therapeutics Inc [CGTX]. The present Moving Average for the last 50 days of trading for this stock 0.4827, while it was recorded at 0.4317 for the last single week of trading, and 1.3737 for the last 200 days.
Cognition Therapeutics Inc [CGTX]: An insightful look at the core fundamentals
Cognition Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.11 and a Current Ratio set at 2.11.
Cognition Therapeutics Inc [CGTX]: Institutional Ownership
There are presently around $24.53%, or 24.67%% of CGTX stock, in the hands of institutional investors. The top three institutional holders of CGTX stocks are: VANGUARD GROUP INC with ownership of 1.15 million shares, which is approximately 3.4016%. AWM INVESTMENT COMPANY, INC., holding 0.65 million shares of the stock with an approximate value of $$1.08 million in CGTX stocks shares; and AWM INVESTMENT COMPANY, INC., currently with $$0.83 million in CGTX stock with ownership which is approximately 1.4821%.
